Login to Your Account

Exact to Get $24.5M in Deal with Genzyme

By Catherine Hollingsworth

Thursday, January 29, 2009
After rejecting a hostile bid by Sequenom Inc., Exact Sciences Corp. has entered a $24.5 million deal with Genzyme Corp. in a move that could help grow Exact's cancer diagnostics business. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription